A detailed history of Appleton Partners Inc transactions in Pfizer Inc stock. As of the latest transaction made, Appleton Partners Inc holds 11,964 shares of PFE stock, worth $341,691. This represents 0.03% of its overall portfolio holdings.

Number of Shares
11,964
Previous 15,095 20.74%
Holding current value
$341,691
Previous $419,000 20.05%
% of portfolio
0.03%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 02, 2024

SELL
$25.26 - $29.6 $79,089 - $92,677
-3,131 Reduced 20.74%
11,964 $335,000
Q1 2024

Apr 01, 2024

SELL
$25.89 - $29.73 $79,611 - $91,419
-3,075 Reduced 16.92%
15,095 $419,000
Q4 2023

Jan 02, 2024

SELL
$26.13 - $33.94 $77,501 - $100,666
-2,966 Reduced 14.03%
18,170 $523,000
Q3 2023

Oct 03, 2023

SELL
$32.09 - $37.51 $49,001 - $57,277
-1,527 Reduced 6.74%
21,136 $701,000
Q2 2023

Jul 10, 2023

SELL
$36.12 - $41.79 $416,463 - $481,838
-11,530 Reduced 33.72%
22,663 $831,000
Q1 2023

Apr 10, 2023

BUY
$39.39 - $51.28 $106,195 - $138,250
2,696 Added 8.56%
34,193 $1.4 Million
Q4 2022

Jan 19, 2023

BUY
$41.75 - $54.5 $31,730 - $41,420
760 Added 2.47%
31,497 $1.61 Million
Q3 2022

Oct 27, 2022

BUY
$43.76 - $53.42 $247,987 - $302,731
5,667 Added 22.6%
30,737 $1.35 Million
Q2 2022

Jul 08, 2022

BUY
$46.53 - $55.17 $61,512 - $72,934
1,322 Added 5.57%
25,070 $1.31 Million
Q1 2022

Apr 05, 2022

SELL
$45.75 - $56.69 $23,561 - $29,195
-515 Reduced 2.12%
23,748 $1.23 Million
Q4 2021

Feb 03, 2022

SELL
$41.32 - $61.25 $62,765 - $93,038
-1,519 Reduced 5.89%
24,263 $1.43 Million
Q3 2021

Oct 14, 2021

BUY
$39.25 - $50.42 $33,441 - $42,957
852 Added 3.42%
25,782 $1.11 Million
Q2 2021

Jul 07, 2021

SELL
$35.91 - $40.68 $21,941 - $24,855
-611 Reduced 2.39%
24,930 $976,000
Q1 2021

Apr 19, 2021

SELL
$33.49 - $37.77 $38,781 - $43,737
-1,158 Reduced 4.34%
25,541 $925,000
Q4 2020

Jan 19, 2021

BUY
$33.47 - $42.56 $10,308 - $13,108
308 Added 1.17%
26,699 $983,000
Q3 2020

Oct 14, 2020

SELL
$31.75 - $37.25 $7,778 - $9,126
-245 Reduced 0.92%
26,391 $969,000
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $20,300 - $24,627
-674 Reduced 2.47%
26,636 $871,000
Q1 2020

May 04, 2020

SELL
$27.03 - $38.62 $190,750 - $272,541
-7,057 Reduced 20.53%
27,310 $891,000
Q4 2019

Jan 13, 2020

SELL
$32.92 - $37.36 $116,273 - $131,955
-3,532 Reduced 9.32%
34,367 $1.35 Million
Q3 2019

Nov 04, 2019

SELL
$32.49 - $42.13 $146,367 - $189,795
-4,505 Reduced 10.62%
37,899 $1.36 Million
Q2 2019

Jul 25, 2019

BUY
$36.98 - $41.52 $111,161 - $124,809
3,006 Added 7.63%
42,404 $1.84 Million
Q1 2019

Apr 17, 2019

SELL
$37.5 - $41.2 $29,737 - $32,671
-793 Reduced 1.97%
39,398 $1.67 Million
Q4 2018

Jan 17, 2019

SELL
$38.47 - $43.86 $40,624 - $46,316
-1,056 Reduced 2.56%
40,191 $1.75 Million
Q3 2018

Oct 09, 2018

BUY
$34.47 - $41.81 $4,929 - $5,978
143 Added 0.35%
41,247 $1.82 Million
Q2 2018

Aug 08, 2018

SELL
$32.98 - $35.16 $135,119 - $144,050
-4,097 Reduced 9.06%
41,104 $1.49 Million
Q1 2018

Apr 11, 2018

SELL
$31.91 - $37.02 $39,057 - $45,312
-1,224 Reduced 2.64%
45,201 $1.6 Million
Q4 2017

Jan 12, 2018

BUY
$33.26 - $35.29 $24,845 - $26,361
747 Added 1.64%
46,425 $1.68 Million
Q3 2017

Oct 12, 2017

BUY
$31.0 - $34.15 $1.42 Million - $1.56 Million
45,678
45,678 $1.63 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Appleton Partners Inc Portfolio

Follow Appleton Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Appleton Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Appleton Partners Inc with notifications on news.